Employees: 01 (2023.0)Legal category: 5485Size: PMECreation date: 2009-12-08 (16 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: GOND-PONTOUVRE (16160), Charente
PHARMACIE DE LA TOUVRE : revenue, balance sheet and financial ratios
PHARMACIE DE LA TOUVRE is a French company
founded 16 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in GOND-PONTOUVRE (16160),
this company of category PME
shows in 2024 a revenue of 1.3 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE LA TOUVRE (SIREN 519093074)
Indicator
2025
2024
2023
2021
2020
2019
2018
2017
2016
Revenue
N/C
1 285 679 €
N/C
N/C
N/C
N/C
N/C
786 443 €
N/C
Net income
39 653 €
72 257 €
80 343 €
85 451 €
43 898 €
87 220 €
38 170 €
73 330 €
-72 984 €
EBITDA
N/C
90 338 €
N/C
N/C
N/C
N/C
N/C
82 075 €
N/C
Net margin
N/C
5.6%
N/C
N/C
N/C
N/C
N/C
9.3%
N/C
Revenue and income statement
In 2025, PHARMACIE DE LA TOUVRE generates positive net income of 40 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
39 653 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 4%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 87%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
3.741%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
86.718%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE LA TOUVRE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2023
2024
2025
Debt ratio
56.598
36.147
59.169
38.875
25.336
18.547
8.814
5.441
3.741
Financial autonomy
58.386
67.012
54.791
63.359
68.402
75.063
83.071
83.368
86.718
Repayment capacity
None
2.576
None
None
None
None
None
0.757
None
Cash flow / Revenue
None%
9.752%
None%
None%
None%
None%
None%
5.724%
None%
Sector positioning
Debt ratio
3.742025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Excellent
In 2025, the debt ratio of PHARMACIE DE LA TOUVRE (3.74) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
86.72%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Excellent+12 pts over 3 years
In 2025, the financial autonomy of PHARMACIE DE LA TOUVRE (86.7%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
0.76 years2024
2024
Q1: 0.52 years
Med: 3.19 years
Q3: 7.6 years
Good
In 2024, the repayment capacity of PHARMACIE DE LA TOUVRE (0.76) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 321.41. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
321.413
Liquidity indicators evolution PHARMACIE DE LA TOUVRE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2023
2024
2025
Liquidity ratio
166.536
169.284
187.289
190.666
149.029
200.009
289.615
283.578
321.413
Interest coverage
None
9.369
None
None
None
None
None
1.427
None
Sector positioning
Liquidity ratio
321.412025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Excellent
In 2025, the liquidity ratio of PHARMACIE DE LA TOUVRE (321.41) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
1.43x2024
2024
Q1: 0.0x
Med: 2.35x
Q3: 7.73x
Average
In 2024, the interest coverage of PHARMACIE DE LA TOUVRE (1.4x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE LA TOUVRE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2023
2024
2025
Operating WCR
0 €
100 209 €
0 €
0 €
0 €
0 €
0 €
154 950 €
0 €
Inventory turnover (days)
0
33
0
0
0
0
0
32
0
Customer payment term (days)
0
2
0
0
0
0
0
8
0
Supplier payment term (days)
0
38
0
0
0
0
0
47
0
Positioning of PHARMACIE DE LA TOUVRE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DE LA TOUVRE is estimated at
629 892 €
(range 427 448€ - 988 388€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
427k€629k€988k€
629 892 €Range: 427 448€ - 988 388€
NAF 5 année 2025
Valuation method used
Net Income Multiple
39 653 €
×
15.9x
=629 893 €
Range: 427 448€ - 988 388€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE LA TOUVRE with other companies in the same sector:
Frequently asked questions about PHARMACIE DE LA TOUVRE
What is the revenue of PHARMACIE DE LA TOUVRE ?
The revenue of PHARMACIE DE LA TOUVRE in 2024 is 1.3 M€.
Is PHARMACIE DE LA TOUVRE profitable?
Yes, PHARMACIE DE LA TOUVRE generated a net profit of 40 k€ in 2025.
Where is the headquarters of PHARMACIE DE LA TOUVRE ?
The headquarters of PHARMACIE DE LA TOUVRE is located in GOND-PONTOUVRE (16160), in the department Charente.
Where to find the tax return of PHARMACIE DE LA TOUVRE ?
The tax return of PHARMACIE DE LA TOUVRE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE LA TOUVRE operate?
PHARMACIE DE LA TOUVRE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart